Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|January 25, 2012
Modeling natural anti-inflammatory compounds by molecular topologyMaría Galvez-Llompart, Riccardo Zanni, Ramón García-DomenechFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 9, 2023
Elucidating the mechanism of action of mycotoxins through machine learning-driven QSAR models: Focus on lipid peroxidationMaria Galvez-Llompart, Riccardo Zanni, Lara Manyes, et al.Expert Opinion on Drug Discovery|June 5, 2020
What place does molecular topology have in today's drug discovery?Riccardo Zanni, Maria Galvez-Llompart, Ramon Garcia-Domenech, et al.Expert Opinion on Drug Discovery|January 8, 2013
Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistaminesJorge Galvez, Maria Galvez-Llompart, Riccardo Zanni, et al.ACS Omega|July 21, 2020
Molecular Topology QSAR Strategy for Crop Protection: New Natural Fungicides with Chitin Inhibitory ActivityMaria Galvez-Llompart, Riccardo Zanni, Jorge Galvez, et al.Expert Opinion on Drug Discovery|July 3, 2015
Latest advances in molecular topology applications for drug discoveryRiccardo Zanni, Maria Galvez-Llompart, Ramón García-Domenech, et al.Current Computer-Aided Drug Design|April 15, 2014
QSAR multi-target in drug discovery: a reviewRiccardo Zanni, María Gálvez-Llompart, Jorge Gálvez, et al.Journal of Chemical Information and Modeling|March 18, 2021
Macrolides May Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Entry into Cells: A Quantitative Structure Activity Relationship Study and Experimental ValidationJorge Galvez, Riccardo Zanni, Maria Galvez-Llompart, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2022
How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless DiseaseMaria Galvez-Llompart, Riccardo Zanni, Ramon Garcia-Domenech, et al.Current Neuropharmacology|December 1, 2017
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?Riccardo Zanni, Ramon Garcia-Domenech, Maria Galvez-Llompart, et al.Pageof 3